GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Other Net Income (Loss)

3SBio, (FRA:YFK) Other Net Income (Loss) : €-0.0 Mil (TTM As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Other Net Income (Loss)?

3SBio,'s Other Net Income (Loss) for the six months ended in Dec. 2016 was €0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2016 was €-0.0 Mil.

3SBio,'s quarterly Other Net Income (Loss) increased from Dec. 2015 (€-0.0 Mil) to Jun. 2016 (€-0.0 Mil) and increased from Jun. 2016 (€-0.0 Mil) to Dec. 2016 (€0.0 Mil).

3SBio,'s annual Other Net Income (Loss) increased from Dec. 2014 (€-0.0 Mil) to Dec. 2015 (€0.0 Mil) but then stayed the same from Dec. 2015 (€0.0 Mil) to Dec. 2016 (€0.0 Mil).


3SBio, Other Net Income (Loss) Historical Data

The historical data trend for 3SBio,'s Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Other Net Income (Loss) Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

3SBio, Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio, Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines